Results 21 to 30 of about 18,389 (170)

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases

open access: yesFrontiers in Neurology, 2022
Tumefactive demyelinating lesions (TDL) represent a diagnostic dilemma for clinicians, and in rare atypical cases a collaboration of a neuroradiologist, a neurologist, and a neuropathologist is warranted for accurate diagnosis.
Aigli G. Vakrakou   +5 more
doaj   +3 more sources

Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients [PDF]

open access: yesAnnals of Clinical and Translational Neurology, 2023
Objective To describe demographic, clinical, and radiographic features of tumefactive demyelination (TD) and identify factors associated with severe attacks and poor outcomes.
Mahboubeh Fereidan‐Esfahani   +8 more
doaj   +2 more sources

Tumefactive demyelination presenting during bevacizumab treatment [PDF]

open access: yesBMJ Case Rep, 2015
We report the emergence of tumefactive demyelination during treatment with intravitreal bevacizumab (Avastin). This is of particular significance given that bevacizumab is currently being assessed as a potential treatment option for neuromyelitis optica,
Rossiter, David   +7 more
core   +2 more sources

RETRACTION: A Rare Case of Tumefactive Demyelination of Brain: A Case Report and Literature Review [PDF]

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
RETRACTION: P. Inban, O. Akuma, Z. Elavia, C. M. Akuma, M. Singh, M. P. Kachhadia, and A. B. J. Musiime, "A Rare Case of Tumefactive Demyelination of Brain: A Case Report and Literature Review," Clinical Case Reports 11, no. 12 (2023): e8369. https://doi.org/10.1002/ccr3.8369.
wiley   +2 more sources

Progressive Tumefactive Demyelination as the Only Result of Extensive Diagnostic Work-Up: A Case Report [PDF]

open access: yesFrontiers in Neurology, 2021
Tumefactive demyelinating lesions belong to the rare variants of multiple sclerosis, posing a diagnostic challenge since it is difficult to distinguish them from a neoplasm or other brain lesions and they require a careful differential diagnosis.
Pavel Štourač   +11 more
doaj   +2 more sources

The Impact of Adding Optical Coherence Tomography in MS Diagnostic Criteria on the Classification of Tumefactive Demyelination [PDF]

open access: yesJ Neurol Sci
BACKGROUND: Diagnosing de novo tumefactive demyelination (TD) is challenging, with lower rates of cerebrospinal fluid (CSF) oligoclonal bands and lower female-to-male ratio than typical- onset multiple sclerosis (MS).
Guido, Fiorella S.   +13 more
core   +2 more sources

Tumefactive Demyelination Lesions: Report on Three Cases

open access: yesActa Neurologica Taiwanica
Purpose: Tumefactive demyelination (TD) lesion and its subtype Balo’s concentric sclerosis (BCS), are rare manifestations of central nervous system demyelinating disease.
Chi-Ju Lin   +5 more
doaj   +2 more sources

Tumefactive demyelination in older adults: A scoping review of published cases [PDF]

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical
Tumefactive demyelinating lesions (TDLs) are rare in older populations. In this scoping review we conducted a PUBMED search for published cases of TDLs in patients aged ≥55 years.
Carla De Pasquale, Todd A. Hardy
doaj   +2 more sources

Decisive role of brain biopsy in atypical tumefactive demyelinating lesions: A case report [PDF]

open access: yesRadiology Case Reports
In neuroimaging, tumefactive demyelinating lesions (TDLs), which are rare inflammatory lesions of the central nervous system, can sometimes resemble infectious or malignant processes. Radiologic distinction is frequently made more difficult by their huge
Nazlı Gamze Bülbül, MD   +8 more
doaj   +2 more sources

Tumefactive demyelination—A rare presentation of Anti-MOG Syndrome [PDF]

open access: yesAnnals of Indian Academy of Neurology, 2022
Sesh Sivadasan, Rajalakshmi Poyuran
doaj   +2 more sources

Home - About - Disclaimer - Privacy